These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 26082587)
41. Atopic dermatitis: Burden of illness, quality of life, and associated complications. Drucker AM Allergy Asthma Proc; 2017 Jan; 38(1):3-8. PubMed ID: 28052794 [TBL] [Abstract][Full Text] [Related]
42. Burden of Atopic dermatitis in Canada. Barbeau M; Bpharm HL Int J Dermatol; 2006 Jan; 45(1):31-6. PubMed ID: 16426372 [TBL] [Abstract][Full Text] [Related]
43. Economic burden of injuries in South Korea. Lim SJ; Chung WJ; Cho WH Inj Prev; 2011 Oct; 17(5):291-6. PubMed ID: 21622932 [TBL] [Abstract][Full Text] [Related]
44. Atopic dermatitis is associated with a decrement in health-related quality of life. Kiebert G; Sorensen SV; Revicki D; Fagan SC; Doyle JJ; Cohen J; Fivenson D Int J Dermatol; 2002 Mar; 41(3):151-8. PubMed ID: 12010340 [TBL] [Abstract][Full Text] [Related]
45. Economic cost of dementia patients according to the limitation of the activities of daily living in Korea. Kang IO; Lee SY; Kim SY; Park CY Int J Geriatr Psychiatry; 2007 Jul; 22(7):675-81. PubMed ID: 17171741 [TBL] [Abstract][Full Text] [Related]
46. Cost of atopic dermatitis and eczema in the United States. Ellis CN; Drake LA; Prendergast MM; Abramovits W; Boguniewicz M; Daniel CR; Lebwohl M; Stevens SR; Whitaker-Worth DL; Cheng JW; Tong KB J Am Acad Dermatol; 2002 Mar; 46(3):361-70. PubMed ID: 11862170 [TBL] [Abstract][Full Text] [Related]
47. [Survey of economic burden of hepatitis B-related diseases in 12 areas in China]. Ma QS; Liang S; Xiao HW; Zhang SX; Zhuang GH; Zou YH; Tan HZ; Liu JC; Zhang YH; Xu AQ; Zhang L; Feng XX; Hu DS; Wang FZ; Cui FQ; Liang XF Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Jul; 38(7):868-876. PubMed ID: 28738457 [No Abstract] [Full Text] [Related]
48. Cost-effectiveness of tolvaptan for euvolemic or hypervolemic hyponatremia. Lee MY; Kang HJ; Park SY; Kim HL; Han E; Lee EK Clin Ther; 2014 Sep; 36(9):1183-94. PubMed ID: 25151571 [TBL] [Abstract][Full Text] [Related]
49. Economic evaluation of the societal costs of hepatitis B in South Korea. Yang BM; Paik SW; Hahn OS; Yi DH; Choi MS; Payne S J Gastroenterol Hepatol; 2001 Mar; 16(3):301-8. PubMed ID: 11339422 [TBL] [Abstract][Full Text] [Related]
50. The burden of atopic dermatitis: impact on the patient, family, and society. Carroll CL; Balkrishnan R; Feldman SR; Fleischer AB; Manuel JC Pediatr Dermatol; 2005; 22(3):192-9. PubMed ID: 15916563 [TBL] [Abstract][Full Text] [Related]
51. The economics of topical immunomodulators for the treatment of atopic dermatitis. Abramovits W; Boguniewicz M; Paller AS; Whitaker-Worth DL; Prendergast MM; Tokar M; Tong KB Pharmacoeconomics; 2005; 23(6):543-66. PubMed ID: 15960552 [TBL] [Abstract][Full Text] [Related]
52. Cost-effectiveness of Tofacitinib in the Treatment of Moderate to Severe Rheumatoid Arthritis in South Korea. Lee MY; Park SK; Park SY; Byun JH; Lee SM; Ko SK; Lee EK Clin Ther; 2015 Aug; 37(8):1662-76.e2. PubMed ID: 26243076 [TBL] [Abstract][Full Text] [Related]
53. The Socioeconomic Burden of Acquired Brain Injury among the Korean Patients over 20 Years of Age in 2015-2017: a Prevalence-Based Approach. Lee YS; Lee HY; Leigh JH; Choi Y; Kim HK; Oh BM Brain Neurorehabil; 2021 Nov; 14(3):e24. PubMed ID: 36741222 [TBL] [Abstract][Full Text] [Related]
54. The socioeconomics of atopic dermatitis. Chung J; Simpson EL Ann Allergy Asthma Immunol; 2019 Apr; 122(4):360-366. PubMed ID: 30597208 [TBL] [Abstract][Full Text] [Related]
55. Atopic dermatitis in Italian children: evaluation of its economic impact. Ricci G; Bendandi B; Pagliara L; Patrizi A; Masi M J Pediatr Health Care; 2006; 20(5):311-5. PubMed ID: 16962436 [TBL] [Abstract][Full Text] [Related]
56. Economic burden of cutaneous infections in children and adults with atopic dermatitis. Sandhu JK; Salame N; Ehsani-Chimeh N; Armstrong AW Pediatr Dermatol; 2019 May; 36(3):303-310. PubMed ID: 30968453 [TBL] [Abstract][Full Text] [Related]
57. Prevalence and socio-economic burden of heart failure in an aging society of South Korea. Lee H; Oh SH; Cho H; Cho HJ; Kang HY BMC Cardiovasc Disord; 2016 Nov; 16(1):215. PubMed ID: 27832754 [TBL] [Abstract][Full Text] [Related]
58. Results of a Markov model analysis to assess the cost-effectiveness of a single tablet of fixed-dose amlodipine and atorvastatin for the primary prevention of cardiovascular disease in Korea. Liew D; Park HJ; Ko SK Clin Ther; 2009 Oct; 31(10):2189-203; discussion 2150-1. PubMed ID: 19922890 [TBL] [Abstract][Full Text] [Related]
59. Cost of depression in Europe. Sobocki P; Jönsson B; Angst J; Rehnberg C J Ment Health Policy Econ; 2006 Jun; 9(2):87-98. PubMed ID: 17007486 [TBL] [Abstract][Full Text] [Related]
60. Burden of atopic dermatitis in Asia. Tsai TF; Rajagopalan M; Chu CY; Encarnacion L; Gerber RA; Santos-Estrella P; Llamado LJQ; Tallman AM J Dermatol; 2019 Oct; 46(10):825-834. PubMed ID: 31436343 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]